PhaseBio Pharmaceuticals, Inc. (PHAS)
Total Non-Current Liabilities
$114.89M
Quarterly · Period ending: · USD
PHAS Total Non-Current Liabilities
Latest reported$114.89Mperiod ending
Latest reported$114.89Mperiod ending
PHAS Quarterly Total Non-Current Liabilities ($93.92M → $114.89M)
Quarterly total non-current liabilities
High-resolution chart · PNG
PHAS total non-current liabilities history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Total Non-Current Liabilities (USD) |
|---|---|
| 114,885,000 | |
| 119,371,000 | |
| 125,691,000 | |
| 106,597,000 | |
| 103,638,000 | |
| 75,742,000 | |
| 60,599,000 | |
| 42,485,000 | |
| 26,615,000 | |
| 15,877,000 | |
| 14,037,000 | |
| 9,437,000 | |
| 10,083,000 | |
| 8,507,000 | |
| 7,522,000 | |
| 135,974,000 | |
| 4,130,000 | |
| 93,920,000 |